Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8525
Fax+1 214-645-8526
Dr. Aguilera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Todd Aguilera is a Radiation Oncologist based in Dallas, TX, currently working as an Assistant Professor at the University of Texas Southwestern Medical Center since 2017. He completed his residency in Radiation Oncology at Stanford Health Care and his internship in Internal Medicine at the University of California (San Diego) Medical Center. He earned his MD and PhD in Biomedical Sciences from the University of California San Diego School of Medicine. Dr. Aguilera has contributed publications to various scientific journals, including topics on pancreatic cancer and therapy resistance in breast cancer. He is also involved in clinical trials, such as the INNATE trial focusing on immunotherapy for rectal cancer.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2012 - 2016
University of California (San Diego) Medical CenterInternship, Internal Medicine, 2011 - 2012
University of California San Diego School of MedicineMD PhD, Biomedical Sciences, 2003 - 2011
University of California San Diego School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - Present
TX State Medical License 2016 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer Start of enrollment: 2020 Apr 24
Publications & Presentations
PubMed
- Exploring radiomic and topological features to evaluate treatment response in rectal cancer.Haozhao Zhang, Jiaqi Liu, Naveen Rajamohan, Nina N Sanford, Gaurav Khatri
Physics in Medicine and Biology. 2025-10-22 - Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma.Katy L Swancutt, Eslam A Elghonaimy, James H Nicholson, Laurentiu M Pop, Brock J Sishc
Molecular Cancer Therapeutics. 2025-10-14 - Quality and Quantity: Dual Benefits of Ablative Radiation in Oligometastatic Pancreatic Cancer.Todd A Aguilera, Ahmed M Elamir, Ethan B Ludmir
Seminars in Radiation Oncology. 2025-10-01
Journal Articles
- Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence Following Radiation Therapy in Immunosuppressed PatientsTodd Aguilera, MD, Clinical Cancer Research
Press Mentions
Presurgical Radiation May Curb Pancreatic Cancer RecurrenceJuly 2nd, 2025- What Does the Rectal Cancer Trial’s 100% Remission Rate Mean for Young Patients?July 21st, 2022
UTSW Receives $34 Million CPRIT Award for Cancer Research and Faculty RecruitmentSeptember 19th, 2017- Join now to see all
Grant Support
- Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approachUT SOUTHWESTERN MEDICAL CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
